37,984
2.99%
1,137
26
bio
Breakthroughs that change patients' lives.languages
englishinterests
Analysis
History
followers vs
Feed
Jan 01 1970 GMT00:33
captions
COVID-19 disproportionately affects Black, Native American and Latinx communities. A clinical trial to evaluate the safety and efficacy of an investigational vaccine for COVID-19 is currently enrolling volunteers. Represent your community by volunteering. Get started here: https://bit.ly/3b9O0pW
Jan 01 1970 GMT00:33
captions
Today on World Humanitarian Day we celebrate the extraordinary efforts of aid workers to ensure basic health services and care, despite exceptional challenges. As part of our commitment to helping during times of crisis, we are partnering with @rescueorg to address in refugee settings. To learn more about this work, check out the link in our bio.
Photo credit: IRC
Jan 01 1970 GMT00:33
captions
For over 170 years, we've delivered some of the most important medical innovations in history.
🔬 Our passion for , for delivering excellence and for people's permeates everything we do.
💪 Every day, we work toward a healthier world by inventing, developing and championing and .
💙 Our purpose: Breakthroughs that change patients’ lives.
.
.
.
.
Jan 01 1970 GMT00:33
captions
When it comes to ending devastating neglected tropical diseases like trachoma, it’s not just about what one sector or organization can do, but rather what’s possible when partners work together toward a common goal. @devex_com details how our longstanding partnership with @itiatlanta, @thecartercenter, @sightsavers and many others to fight trachoma has led to great progress in our collective mission to eliminate the world’s leading infectious cause of blindness.
Check out the link in our bio to learn more.
Photo Credit: International Trachoma Initiative
.
.
.
.
Jan 01 1970 GMT00:33
captions
Jamil, Felicia, Julia, Beth. These are four of the tens of thousands of people who are living with metastatic breast cancer – and their voices 🗣 deserve to be heard. See our Story 👆 to learn more about .
If you or someone you love is living with mBC, be sure to visit FindYourMBCVoice.com to find resources and support that will help you find your voice.
.
.
.
.
.
Posting times
All times are shown in GMT
by days
by hours
Best performing posts
likes
4,715
90
Sep 02 2020 GMT15:55
captions
We’re leaving no stone unturned in the fight against . Watch the full video (link in bio) for a behind-the-scenes look at the scientific frontlines during this pivotal time.
.
.
.
.
analysis
This post got 315% more likes
compared to @pfizerinc's average. It uses the average amount of hashtags
and its caption is 41% shorter
4,687
29
Oct 02 2020 GMT16:28
captions
Meet our manufacturers inspiring future creators.💡⚙️📦 @shopfloornam
.
.
.
.
analysis
This post got 312% more likes
compared to @pfizerinc's average. It uses 38% more hashtags
and its caption is 70% shorter
2,048
43
Jul 27 2020 GMT21:34
captions
UPDATE: Our mRNA-based candidate against SARS-CoV-2 (BNT162b2) is moving into Phase 2/3 clinical development and enrollment. Learn more about our work with BioNTech to investigate a vaccine candidate against at the link in our bio.
.
.
.
.
analysis
This post got 80% more likes
compared to @pfizerinc's average. It uses 63% more hashtags
and its caption is 21% shorter
comments
4,715
90
Sep 02 2020 GMT15:55
captions
We’re leaving no stone unturned in the fight against . Watch the full video (link in bio) for a behind-the-scenes look at the scientific frontlines during this pivotal time.
.
.
.
.
analysis
This post got 246% more likes
compared to @pfizerinc's average. It uses the average amount of hashtags
and its caption is 41% shorter
1,341
44
Jul 20 2020 GMT13:51
captions
Our long heritage 📘
Of producing life-changing 👩🏽🔬
Is built on outstanding 💡
Not only in & development 🧪
But also in 📦
.
.
Visit pfizer.com to see how we're leveraging this deep knowledge to support the global supply of a potential vaccine.
.
.
analysis
This post got 69% more likes
compared to @pfizerinc's average. It uses 100% more hashtags
and its caption is 12% shorter
2,048
43
Jul 27 2020 GMT21:34
captions
UPDATE: Our mRNA-based candidate against SARS-CoV-2 (BNT162b2) is moving into Phase 2/3 clinical development and enrollment. Learn more about our work with BioNTech to investigate a vaccine candidate against at the link in our bio.
.
.
.
.
analysis
This post got 65% more likes
compared to @pfizerinc's average. It uses 63% more hashtags
and its caption is 21% shorter